Cyproterone Acetate and Risk of Meningioma: A Nationwide Cohort Study

    June 2021 in “ Journal of neurology, neurosurgery and psychiatry ”
    A. B. Mikkelsen, Iben Katinka Greiber, Nikolai Madrid Scheller, Malene Hilden, Øjvind Lidegaard
    TLDR Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.
    This nationwide cohort study investigated the association between cyproterone acetate (CPA) use and the risk of meningioma in Denmark. The study included individuals born between 1930 and 2000, followed from age 15 or later until 2017. The findings indicated that high cumulative doses of CPA significantly increased the risk of meningioma, with a 6-20 fold higher risk compared to low doses. This led to the European Medicines Agency recommending a restriction of CPA to less than 10 mg per day. The study underscores the importance of monitoring CPA dosage to mitigate the risk of meningioma.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 82 results

      community Ru58841 for a female w male pattern baldness

      in General  166 upvotes 4 months ago
      A user is considering using RU58841 for female pattern baldness and is also planning to use Minoxidil. They are hesitant to ask their doctor for spironolactone due to its cosmetic nature and are experiencing significant hair loss possibly due to stress and hormonal issues.

      community Doctors won't let me try bicalutamide or fin

      in Female  7 upvotes 3 years ago
      Hair loss treatments discussed include 200mg Spiro, bicalutamide, and finasteride. Endocrinologist advises against bicalutamide and finasteride due to potency and risks.

      community Spironolactone for hair loss??

      in Product  6 upvotes 2 years ago
      Hair loss treatments discussed include Minoxidil, Finasteride, and Spironolactone. One user shares success with Finasteride, Minoxidil, and low-dose Cyproterone Acetate, but warns against long-term use of oral anti-androgens.

      community Extreme regimen and still miniaturized hairs. AGA is just impossible to beat.

      in Insane  29 upvotes 2 years ago
      A user's extreme regimen for hair loss, which includes taking oral and topical medications such as minoxidil, dutasteride, cyproterone acetate and bicalutamide, but still experiencing miniaturization. Suggestions were made to try other treatments such as RU58841 and Pyrilutamide, while also considering mental health treatment and advice on lookmaxxing.

      community 5 months of nuking T, 2 months of minoxidil

      in Transgender  485 upvotes 3 months ago
      The user transitioned from finasteride to Cyproterone and started using Minoxidil, resulting in healthier hair and regrowth. They plan to wean off Minoxidil in a year, depending on regrowth.

    Similar Research

    5 / 1000+ results